×
81 419
Fashion Jobs
NIKE
Art Director, Global Brand Creative Studio – Men’s Lifestyle
Permanent · Beaverton
NIKE
Senior Business Consultant, Onboarding
Permanent · Beaverton
NIKE
sr. Technical Program Manager- Enterprise Data & Analytics
Permanent · Beaverton
NIKE
Product Solution Manager, Digital Workflow
Permanent · Beaverton
NIKE
Senior Product Manager, Order Management
Permanent · Beaverton
FOOT LOCKER
Replenishment Analyst
Permanent · Bradenton
FOOT LOCKER
Senior Manager, Ecommerce, Kids Foot Locker
Permanent · New York
JCPENNEY
Buyer - Men's Furnishings
Permanent · Plano
ESTÉE LAUDER
Senior Manager, Product Project Manager
Permanent · New York
ESTÉE LAUDER
Manager, Global Product Marketing, Lip, Mac
Permanent · New York
ESTÉE LAUDER
Keyholder - Cosmetic Company Store - 20 Hrs - Lighthouse Place Premium Outlets - Michigan City, in
Permanent · Michigan City
ESTÉE LAUDER
Retail Beauty Sales Manager - jo Malone London - Full-Time - Santa Monica Place - Santa Monica, ca
Permanent · Santa Monica
ABERCROMBIE AND FITCH CO.
1st Shift Security Associate
Permanent · Columbus
ABERCROMBIE AND FITCH CO.
2nd Shift Security Associate
Permanent · Columbus
ABERCROMBIE AND FITCH CO.
3rd Shift Security Associate (Full-Time)
Permanent · Columbus
NEW BALANCE
Distribution Supervisor - Afternoons
Permanent · Saint-Louis
BATH & BODY WORKS
Merchandise Planner, Canada
Permanent · Reynoldsburg
ADIDAS
Manager, Digital Site Merchandising
Permanent · Portland
ADIDAS
Retail District Manager, Florida North
Permanent · Orlando
ADIDAS
Design Director - Fear of God (Footwear-Focus)
Permanent · Los Angeles
KOHLS
Full-Time Loss Prevention Supervisor
Permanent · Glendale
KOHLS
Full-Time Loss Prevention Supervisor
Permanent · Simpsonville
By
Reuters
Published
Feb 27, 2018
Reading time
2 minutes
Share
Download
Download the article
Print
Click here to print
Text size
aA+ aA-

Fitbit slumps as new smartwatch fails to excite

By
Reuters
Published
Feb 27, 2018

Fitbit Inc’s shares fell 14 percent in early trading on Tuesday after the company said its newly launched smartwatch was not selling as expected, raising concerns about the company’s ability to become profitable again in the near term.



Photo: Reuters



The wearable device maker on Monday posted its fifth straight quarter of loss, gave a disappointing forecast for the first quarter, and acknowledged competitive pressures in the smartwatch market.

Fitbit, whose colorful fitness-tracking wrist bands became must-haves for fitness enthusiasts a few years ago, has struggled in recent quarters as Apple and Samsung step up their game in the wearable devices market and China’s Xiaomi woos users with cheaper products.

“Significant declines in devices sold year-over-year and significant quarterly losses do not inspire confidence in the company’s ability to quickly return to profitability,” Wedbush Securities analyst Alicia Reese said in a note.

Fitbit’s shares, which are trading 76 percent below their IPO price, have fallen 10 percent in the past 12 months. The short interest on Fitbit’s outstanding shares is 16 percent.

Analysts have said the stock price will continue to be under pressure in the near-term.

The company said on Monday that its Ionic smartwatch, launched in October and priced at $300, was not selling as expected because it was not a “mass-appeal” smartwatch.

Executives tried to reassure investors that the company was focused on selling more smartwatches that would attract a broader user base in 2018.

For comparison, Apple’s smartwatches range from $329-$1,399.

“We would become further negative on the stock if coming smartwatch launches do not sufficiently improve or differentiate the ecosystem,” Morgan Stanley analysts said.

Fitbit Chief Executive James Park also reiterated the company’s focus on healthcare services - using fitness data to connect users with doctors, hospitals and lifestyle coaches. This business is expected to give the company a more predictable stream of revenue.

Earlier this month, Fitbit acquired startup Twine Health to boost its healthcare services.

Analysts, however, remained skeptical about how quickly this business will ramp.

“The company has an excellent opportunity ahead with medical applications, but it is unlikely that subscription revenue will contribute meaningfully before 2019,” Wedbush’s Reese wrote.

© Thomson Reuters 2022 All rights reserved.